The 5 key players our Oral GLP-1 Drugs report profiles.
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Novo Nordisk A/S |
novo.com (opens in a new tab) | 495 reports |
| 2 | Eli Lilly and Company |
lilly.com (opens in a new tab) | 1,056 reports |
| 3 | Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 4 | Structure Therapeutics | — | 33 reports |
| 5 | Viking Therapeutics | — | 33 reports |
One report for each place. Each tile opens that place's report.
Compare all 33 places for Oral GLP-1 Drugs, with active trials
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.